Susquehanna International Group’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
79,551
-6,407
| -7% | -$11.5K | ﹤0.01% | 5743 |
|
|
2025
Q1 | $164K | Buy |
85,958
+39,045
| +83% | +$74.6K | ﹤0.01% | 5629 |
|
|
2024
Q4 | $101K | Buy |
+46,913
| New | +$101K | ﹤0.01% | 5690 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5946 |
|
|
2024
Q2 | – | Sell |
-43,062
| Closed | -$162K | – | 5970 |
|
|
2024
Q1 | $162K | Buy |
43,062
+8,562
| +25% | +$32.3K | ﹤0.01% | 4795 |
|
|
2023
Q4 | $113K | Sell |
34,500
-30,726
| -47% | -$100K | ﹤0.01% | 5296 |
|
|
2023
Q3 | $211K | Sell |
65,226
-4,564
| -7% | -$14.7K | ﹤0.01% | 4491 |
|
|
2023
Q2 | $313K | Buy |
69,790
+54,618
| +360% | +$245K | ﹤0.01% | 4175 |
|
|
2023
Q1 | $73.1K | Buy |
+15,172
| New | +$73.1K | ﹤0.01% | 5351 |
|
|
2022
Q1 | – | Sell |
-19,357
| Closed | -$103K | – | 6024 |
|
|
2021
Q4 | $103K | Buy |
+19,357
| New | +$103K | ﹤0.01% | 5281 |
|